Retatrutide is a multi-receptor peptide agonist targeting GLP-1, GIP, and glucagon receptors, designed for advanced metabolic research
De behandeling is bedoeld voor mensen met overgewicht of obesitas, waarbij gezondheidsrisicos toenemen en blijvend gewichtsverlies gewenst is onder medische begeleiding
Some of the most common side effects in clinical trials included nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion (dyspepsia), and stomach (abdominal) pain
Someone with good blood sugar control needing appetite suppression might do well on GLP-1 medications
Accessing compounded GLP-1 medications is just one click away Often confused with being a generic version of a drug, a compounded medication is one that has been customized in some way to meet the unique needs of a patient